एपीए उद्धरण

Kaplan, M., Yavuz, F., Kaplan, G. I., Bursa, N., Vuruşkan, E., & Sucu, M. (2021). Elabela as a novel marker: Well-correlated with WIfI amputation risk score in lower extremity arterial disease patients. Anatol J Cardiol.

शिकागो स्टाइल उद्धरण

Kaplan, Mehmet, Fethi Yavuz, Gizem Ilgın Kaplan, Nurbanu Bursa, Ertan Vuruşkan, और Murat Sucu. "Elabela As a Novel Marker: Well-correlated With WIfI Amputation Risk Score in Lower Extremity Arterial Disease Patients." Anatol J Cardiol 2021.

एमएलए उद्धरण

Kaplan, Mehmet, et al. "Elabela As a Novel Marker: Well-correlated With WIfI Amputation Risk Score in Lower Extremity Arterial Disease Patients." Anatol J Cardiol 2021.

चेतावनी: ये उद्धरण हमेशा 100% सटीक नहीं हो सकते हैं.